Data / Form D filings / PROTOX THERAPEUTICS INC
PROTOX THERAPEUTICS INC: Form D filings
PROTOX THERAPEUTICS INC, a biotechnology company in Vancouver, British Columbia, Canada, filed 2 Form D notices with the SEC in 2010. The latest, on October 12, 2010, reports an offering of $59.4 million with nothing sold yet to 2 investors.
Find out what PROTOX THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 885 West Georgia Street - Suite 1210, Box 1014 HSBC Building, Vancouver, British Columbia, Canada, V6C 3
- Phone
- (604) 608-4211
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1384825
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 12, 2010 | New notice | $59,431,399 | $0 | $59,431,399 | 2 | Yet to occur | sec.gov |
| Apr 15, 2010 | New notice | $404,352 | $226,398 | $177,954 | 3 | Mar 16, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Holler | Director | |
| Jack Geltosky | Director | |
| Alexander Giaquinto | Director | |
| Tom D'Orazio | Executive Officer | |
| Nina Merchant | Executive Officer | |
| Fahar Merchant | Executive Officer, Director | |
| Jim Heppell | Director | |
| John Parkinson | Executive Officer | |
| Avtar Dhillon | Director | |
| James Miller | Director |
Every Form D from the week of Oct 11, 2010 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROTOX THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.